Reported number of children receiving antiretroviral therapy in Americas (WHO region)
Americas (WHO region): Reported number of children receiving antiretroviral therapy was 17,000 in 2025. ▲ Rising
Latest (2025)
17,000
Change on year
up 6.2%
Rank
4th
of 8 groups
All-time high
20,000
in 2012
All-time low
2,100
in 2000
Years of data
26
2000–2025
Reported number of children receiving antiretroviral therapy in Americas (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for reported number of children receiving antiretroviral therapy in Americas (WHO region) is 17,000, measured in 2025.
That represents a change of up 6.2% on the previous year and down 15.0% over ten years.
Over the whole period, reported number of children receiving antiretroviral therapy in Americas (WHO region) peaked at 20,000 in 2012 and was at its lowest, 2,100, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Reported number of children receiving antiretroviral therapy in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 2,100 | — |
| 2001 | 2,900 | +38.1% |
| 2002 | 3,600 | +24.1% |
| 2003 | 5,100 | +41.7% |
| 2004 | 5,700 | +11.8% |
| 2005 | 6,700 | +17.5% |
| 2006 | 7,900 | +17.9% |
| 2007 | 9,300 | +17.7% |
| 2008 | 11,000 | +18.3% |
| 2009 | 18,000 | +63.6% |
| 2010 | 19,000 | +5.6% |
| 2011 | 19,000 | +0.0% |
| 2012 | 20,000 | +5.3% |
| 2013 | 20,000 | +0.0% |
| 2014 | 20,000 | +0.0% |
| 2015 | 20,000 | +0.0% |
| 2016 | 19,000 | -5.0% |
| 2017 | 20,000 | +5.3% |
| 2018 | 19,000 | -5.0% |
| 2019 | 19,000 | +0.0% |
| 2020 | 19,000 | +0.0% |
| 2021 | 18,000 | -5.3% |
| 2022 | 18,000 | +0.0% |
| 2023 | 17,000 | -5.6% |
| 2024 | 16,000 | -5.9% |
| 2025 | 17,000 | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7,230 | 2,100 | 18,000 | 10 |
| 2010s | 19,500 | 19,000 | 20,000 | 10 |
| 2020s | 17,500 | 16,000 | 19,000 | 6 |
Countries ranked near Americas (WHO region)
More health data for Americas (WHO region)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 23 (2025)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Number of under-five deaths, annual growth rate -2.83 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.68 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.22 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
Frequently asked questions
- What is reported number of children receiving antiretroviral therapy in Americas (WHO region)?
- Reported number of children receiving antiretroviral therapy in Americas (WHO region) was 17,000 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of children receiving antiretroviral therapy recorded in Americas (WHO region)?
- The highest recorded value was 20,000 in 2012.
- What is the lowest reported number of children receiving antiretroviral therapy recorded in Americas (WHO region)?
- The lowest recorded value was 2,100 in 2000.
- How does Americas (WHO region) rank for reported number of children receiving antiretroviral therapy?
- Americas (WHO region) ranks 4th out of 8 groups with data for 2025.
- Is reported number of children receiving antiretroviral therapy rising or falling in Americas (WHO region)?
- Over the last ten years it is down 15.0%. The long-run trend across the full record is rising.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of children receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).